Quest Diagnostics 2001 Annual Report Download - page 19

INVESTOR INFORMATION
Common Stock
Shares in Quest Diagnostics Incorporated
(ticker symbol: “ DGX” ) are listed on the
New York Stock Exchange. Options on
Quest Diagnostics shares are traded on
the Chicago Board Options Exchange.
Annual Meeting
The annual meeting of shareholders
will be held Tuesday, May 7, 2002, at The
Waldorf-Astoria Hotel, New York, New
York, at 10:30 A.M. A proxy statement and
annual report were mailed to shareholders
of record as of March 11, 2002.
Additional Information
Address all inquiries to:
Investor Relations Department
Quest Diagnostics Incorporated
One Malcolm Avenue
Teterboro, New Jersey 07608
[phone]
email: [e-mail]
Annual Report on Form 10-K
A copy of the Quest Diagnostics 2001
Annual Report on Form 10-K, filed with
the Securities and Exchange Commission,
is contained in this Annual Report.
Additional copies are available without
charge by contacting the Investor
Relations Department.
Internet Access
Corporate news releases, our Annual
Report, Forms 10-K and 10-Q and other
information about the company are
available through Quest Diagnostics’
web site on the Internet:
www.questdiagnostics.com
Transfer Agent and Registrar
Computershare Investor Services
2 North LaSalle Street
Chicago, Illinois 60602
[phone]
Report change of address to
Computershare at the above address.
Quest Diagnostics has not declared any
dividends on common stock.
“Safe Harbor” Statement under the Private
Securities Litigation Reform Act of 1995
The statements in this Annual Report which
are not historical facts or information
are forward-looking statements. These
forward-looking statements involve risks
and uncertainties that could cause the
outcome to be materially different. Certain
of these risks and uncertainties are listed
in the 2001 Annual Report on Form 10-K.
These risks and uncertainties include
heightened competition, the impact of
changes in payer mix, adverse actions
by governmental and other third-party
payers, the impact upon Quest Diagnostics’
collection rates or general or administrative
expenses resulting from compliance with
Medicare administrative policies, an
inability to efficiently integrate acquired
clinical laboratory businesses, adverse
results from pending governmental
investigations, reduction in tests ordered
by existing customers, material increases
in premiums for insurance coverage, denial
of licensure, computer or other system
failures, development of technologies
that substantially alter the practice of
medicine, and changes in interest rates.
CORPORATE INFORMATION
Corporate Headquarters
One Malcolm Avenue
Teterboro, New Jersey 07608
[phone]
Facility Locations
For a complete listing of laboratories
and patient service centers, please visit
Quest Diagnostics’ web site on the
Internet: www.questdiagnostics.com
Compliance
Quest Diagnostics is committed to the
highest ethical standards and complying
with all applicable laws and regulations
that govern its business operations,
including those that apply to reimbursement
for testing under the federal Medicare and
Medicaid programs. Quest Diagnostics
requires that all employees abide by these
laws, rules and regulations and provides
annual compliance training for all
employees. Quest Diagnostics is committed
to protecting the health and safety of its
employees as well as the environmental
resources of the communities in which
it operates.
Privacy
Quest Diagnostics is committed to
protecting the confidentiality of individuals’
private laboratory test results and other
personal information. We are dedicated
to full compliance with all applicable
federal, state and local laws and regulations
regarding the use and disclosure of such
information. For more information about
our privacy practices, please visit our web
site at www.questdiagnostics.com or send a
message to: [e-mail]
or write to: Data Privacy and Security
Officer, Quest Diagnostics, One Malcolm
Avenue, Teterboro, NJ 07608
Diversity
Quest Diagnostics is committed to providing
a diverse work environment where people,
thoughts and ideas are valued. Quest
Diagnostics is also an Equal Employment
Opportunity and Affirmative Action
employer committed to creating and
maintaining a diverse work force that is
reflective of the marketplace. The company
recruits, hires, trains, develops, promotes
and compensates qualified individuals for
all positions regardless of race, color,
gender, age, religion, national origin,
sexual orientation, marital status,
disability, or veteran status.
reach!
reach! (remember every act can help),
our national volunteer program, is
employee-driven and encourages everyone
at Quest Diagnostics to contribute to the
communities where they live and work,
helping to improve the lives of those
who use our services every day. Quest
Diagnostics, through the reach! program,
is a National Supporter of the Juvenile
Diabetes Research Foundation and supports
numerous other charitable organizations
throughout the United States.
Quest Diagnostics Foundation
The Quest Diagnostics Foundation is
committed to supporting health-related
charitable programs. Priority is given
to funding programs and projects that
promote the prevention and early
detection of disease or provide research
for curing disease. Only organizations
established in the United States and
classified as 501(c)(3) are eligible for grants.
Grant requests may be directed to:
Quest Diagnostics Foundation
Executive Director
One Malcolm Avenue
Teterboro, NJ 07608
Trademarks
Quest Diagnostics, Quest, the Sun-Q
symbol and Nichols Institute are registered
trademarks of Quest Diagnostics
Incorporated.
QuestDirect, QuesTest, eMaxx, ChartMaxx,
Quest on Demand and Heptimax are
trademarks of Quest Diagnostics
Incorporated.
Neither this report nor any statement
contained herein is furnished in connection
with any offering of securities or for the
purpose of promoting or influencing the
sale of securities.
©2002 Quest Diagnostics Incorporated.
All rights reserved.
Design: INC DESIGN, incdesign.com
This book is printed on recycled paper.